WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2021

Feb 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2021-02-23

Reporting Person: Winters Chad (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-23	Stock Options (Right to buy)	$274.29	A	1388.00	Acquired	2031-02-23	Common Stock (1388.00)	Direct

Footnotes

F1: This award vests in 4 equal annual installments beginning on 2/23/2022.